UTMD
Utah Medical Products Inc
74.10$
-0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.1% | -1.1% | -47.6% | +39.6% | -23.8% | +52.0% | -35.6% | +35.0% | -10.3% | -10.6% | -55.5% | – | |
| – | -41.7% | -34.3% | +1.5% | +6.8% | -1.4% | -1.2% | +5.1% | +1.5% | -1.2% | -9.5% | -65.0% | – | |
| – | +35.8% | +9.7% | -34.2% | +1.9% | +35.8% | +13.9% | +4.9% | +9.3% | +18.1% | +8.1% | -40.0% | – | |
| – | – | +117.1% | -270.5% | – | – | – | -203.8% | – | -67.3% | -264.0% | – | – | |
| – | -51.6% | -75.6% | +422.7% | +19.1% | -93.4% | +1,944.4% | -72.3% | -47.1% | +303.7% | +19.3% | +3.1% | – | |
| – | -51.6% | – | -2,400.0% | -22.6% | -89.9% | +1,944.4% | -72.3% | -47.1% | +303.7% | +19.3% | +3.1% | – | |
| – | +0.0% | +1.7% | -0.7% | -2.7% | -1.3% | -2.0% | -1.6% | -1.3% | -1.1% | +1.2% | -0.2% | – | |
| – | – | +19.8% | +114.1% | -39.6% | +73.5% | -52.0% | +8.3% | -81.3% | +52.2% | -87.1% | -39.1% | – | |
| – | +3.5% | +271.9% | +80.5% | -31.6% | +57.5% | -45.3% | +5.9% | -63.4% | +20.1% | -43.3% | -4.7% | – | |
| – | +29.8% | -79.8% | -588.2% | – | – | – | -428.4% | – | -28.7% | +10.8% | -92.6% | – | |
| – | +6.2% | +0.2% | -49.6% | +50.9% | -26.7% | +46.2% | -34.1% | +36.5% | -12.5% | -11.5% | -58.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.